Efficacy and safety of dapagliflozin combined with Bailing Capsule in treatment of patients with diabetic kidney disease
Objective To investigate the efficacy and safety of dapagliflozin combined with Bailing Capsule in the treatment of patients with diabetic kidney disease (DKD). Methods A total of 1 162 patients with early-stage DKD who were admitted to The Affiliated Hospital of Qingdao University from January 2019...
Saved in:
| Main Author: | SUI Yingying, ZHOU Quan, HAN Yafei, SUN Jialin, HAN Zhiwu |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Precision Medicine
2025-08-01
|
| Series: | 精准医学杂志 |
| Subjects: | |
| Online Access: | https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/1754471557995-2145427717.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined bailing capsule and conventional therapies in the treatment of chronic renal failure: a meta-analysis and economic evaluation
by: Yumei He, et al.
Published: (2025-06-01) -
The clinical efficacy and action mechanism of Bailing capsule in the treatment of microinflammatory and the condition of malnutrition in maintenance hemodialysis patients
by: HUANG Qiao, et al.
Published: (2018-01-01) -
Discrepancies in Dapagliflozin Response in Terms of Glycemic Control and Body Weight Reduction
by: Ji Eun Jun, et al.
Published: (2025-04-01) -
Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report
by: Lulu Chu, et al.
Published: (2025-01-01) -
Dapagliflozin, a novel oral antidiabetic with an uncertain future
by: Belén Escudero Vilaplana, et al.
Published: (2014-11-01)